Two-Year Treatment with Cyclosporine Microemulsion for Responder Myasthenia Gravis Patients

Publisher： Karger

E-ISSN： 1421-9913|64|3|186-190

ISSN： 0014-3022

Source： European Neurology, Vol.64, Iss.3, 2010-08, pp. : 186-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis

By Shimojima Yasuhiro   Gono Takahisa   Yamamoto Kanji   Hoshi Kenichi   Matsuda Masayuki   Yoshida Kunihiro   Ikeda Shu-ichi  

Clinical Rheumatology, Vol. 23, Iss. 3, 2004-06 ,pp. : 262-265

Springer Publishing Company

Access to resources Recommend Favorite

Early Aggressive Treatment Strategy against Myasthenia Gravis

By  

European Neurology, Vol. 65, Iss. 1, 2010-11 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Restless Legs Syndrome in Patients with Myasthenia Gravis

By  

European Neurology, Vol. 69, Iss. 3, 2012-12 ,pp. : 149-149

Karger

Access to resources Recommend Favorite

Clinical and Electrophysiological Markers in Myasthenia Gravis Patients

By  

European Neurology, Vol. 74, Iss. 1-2, 2015-07 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Two-Year Treatment of Alzheimer’s Disease with Eptastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 2, 1999-02 ,pp. : 139-147

Karger

Access to resources Recommend Favorite